Cyclophosphamide levels in serum and spinal fluid of multiple sclerosis patients treated with immunosuppression
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 58 (2) , 297-303
- https://doi.org/10.1016/0022-510x(83)90224-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Isolation, identification and determination of cyclophosphamide and two of its metabolites in urine of a multiple sclerosis patient by high pressure liquid chromatography and field desorption mass spectrometryJournal of Mass Spectrometry, 1981
- Determination of cyclophosphamide in urine, serum and cerebrospinal fluid of multiple sclerosis patients by field desorption mass spectrometryClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- Cytogenetic toxicity of cyclophosphamide and its metabolites in vitroCytogenetic and Genome Research, 1980
- The kinetics of salivary elimination of cyclophosphamide in man.British Journal of Clinical Pharmacology, 1979
- Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.British Journal of Clinical Pharmacology, 1979
- Decreased half life of cyclophosphamide in patients under continual treatmentPublished by Elsevier ,1979
- Intensive immunosuppression with cyclophosphamide in multiple sclerosisZeitschrift für Neurologie, 1977
- The quantitation of cyclophosphamide in human blood and urine by mass spectrometry-stable isotope dilutionClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Field desorption mass spectrometry of metabolites of the anticancer drug cyclophosphamideJournal of Mass Spectrometry, 1974
- Metabolism of radioactive cyclophosphamide.Animal tests and clinical studiesCancer, 1967